JP2008526705A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526705A5 JP2008526705A5 JP2007548770A JP2007548770A JP2008526705A5 JP 2008526705 A5 JP2008526705 A5 JP 2008526705A5 JP 2007548770 A JP2007548770 A JP 2007548770A JP 2007548770 A JP2007548770 A JP 2007548770A JP 2008526705 A5 JP2008526705 A5 JP 2008526705A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- phenyl
- radical
- butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UQFQONCQIQEYPJ-UHFFFAOYSA-N C[n]1nccc1 Chemical compound C[n]1nccc1 UQFQONCQIQEYPJ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04380289A EP1695971A1 (en) | 2004-12-30 | 2004-12-30 | Substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| PCT/EP2005/014190 WO2006069807A1 (en) | 2004-12-30 | 2005-12-29 | Substituted phenyl-piperazine compounds, their preparation and use in medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526705A JP2008526705A (ja) | 2008-07-24 |
| JP2008526705A5 true JP2008526705A5 (https=) | 2009-02-05 |
Family
ID=34931900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007548770A Pending JP2008526705A (ja) | 2004-12-30 | 2005-12-29 | 置換フェニル−ピペラジン化合物、それらの調製および薬剤における使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20090042904A1 (https=) |
| EP (2) | EP1695971A1 (https=) |
| JP (1) | JP2008526705A (https=) |
| CN (1) | CN101142201A (https=) |
| CA (1) | CA2592832A1 (https=) |
| MX (1) | MX2007007684A (https=) |
| WO (1) | WO2006069807A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006081332A1 (en) * | 2005-01-25 | 2006-08-03 | Epix Delaware, Inc. | Substituted arylamine compounds and their use as 5-ht6 modulators |
| EP1878724A1 (en) | 2006-07-15 | 2008-01-16 | sanofi-aventis | A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles |
| EP1902733A1 (en) * | 2006-09-19 | 2008-03-26 | Laboratorios Del Dr. Esteve, S.A. | Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity |
| EP2020230B1 (en) | 2007-08-01 | 2011-01-19 | Laboratorios del Dr. Esteve S.A. | Combination of at least two 5-HT6-Ligands |
| CA2710039C (en) | 2007-12-26 | 2018-07-03 | Critical Outcome Technologies, Inc. | Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer |
| EP2318406B1 (en) | 2008-07-17 | 2016-01-27 | Critical Outcome Technologies, Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| GB0815781D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| WO2010025375A1 (en) * | 2008-08-29 | 2010-03-04 | Treventis Corporation | Compositions and methods of treating amyloid disease |
| CA2999435A1 (en) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
| WO2015158313A1 (en) | 2014-04-19 | 2015-10-22 | Sunshine Lake Pharma Co., Ltd. | Sulfonamide derivatives and pharmaceutical applications thereof |
| GB201521919D0 (en) * | 2015-12-11 | 2016-01-27 | Electrophoretics Ltd | Isobaric mass labels |
| WO2018106667A1 (en) * | 2016-12-05 | 2018-06-14 | Microbiotix, Inc. | Broad-spectrum inhibitors of filoviruses |
| RU2676100C1 (ru) * | 2018-10-05 | 2018-12-26 | федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ") | Применение производных пиперазина для лечения болезни Альцгеймера и деменций альцгеймеровского типа с нарушенной внутриклеточной кальциевой сигнализацией |
| CN109799297A (zh) * | 2019-02-01 | 2019-05-24 | 广西中烟工业有限责任公司 | 一种卷烟烟气pH调控模型的构建方法及其调控方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19637237A1 (de) * | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazin-Derivate |
| AU736256B2 (en) * | 1997-07-11 | 2001-07-26 | Smithkline Beecham Plc | Novel compounds |
| WO2002092585A1 (en) * | 2001-05-11 | 2002-11-21 | Biovitrum Ab | Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders |
| HRP20040090A2 (en) * | 2001-08-10 | 2004-12-31 | Hoffmann La Roche | Arylsulfonyl derivatives with 5-ht<sub>6</sub> receptor affinity |
-
2004
- 2004-12-30 EP EP04380289A patent/EP1695971A1/en not_active Withdrawn
-
2005
- 2005-12-29 JP JP2007548770A patent/JP2008526705A/ja active Pending
- 2005-12-29 CA CA002592832A patent/CA2592832A1/en not_active Abandoned
- 2005-12-29 WO PCT/EP2005/014190 patent/WO2006069807A1/en not_active Ceased
- 2005-12-29 CN CNA2005800488279A patent/CN101142201A/zh active Pending
- 2005-12-29 US US11/813,161 patent/US20090042904A1/en not_active Abandoned
- 2005-12-29 EP EP05825004A patent/EP1844031A1/en not_active Withdrawn
- 2005-12-29 MX MX2007007684A patent/MX2007007684A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008526705A5 (https=) | ||
| CN100491368C (zh) | 二烷-2-烷基氨基甲酸酯衍生物,其制备及其在治疗学上的应用 | |
| CA2317740A1 (en) | Sulphonamide derivatives for treatment of cns disorders | |
| CN102164920B (zh) | 烷基噻唑氨基甲酸酯衍生物、其制备方法和其作为faah酶抑制剂的用途 | |
| CN1015707B (zh) | 酰胺衍生物的生产方法 | |
| JPWO2002010101A1 (ja) | アミド化合物を配位子とする遷移金属錯体を用いたアルコールの製造方法 | |
| AU2015237788A1 (en) | ROR-gamma modulators and uses thereof | |
| EP1366020A1 (en) | Urea derivatives having vanilloid receptor (vr1) antagonist activity | |
| WO2011044225A1 (en) | Modulators of g protein-coupled receptor 88 | |
| AU2005212868B2 (en) | Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics | |
| AU2013309124A1 (en) | Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes | |
| CN1384827A (zh) | 茚并一,萘并一和苯并环庚二氢噻唑衍生物,它们的制备以及它们作为降低食欲药的用途 | |
| DE69607183T2 (de) | Benzothiazolone-derivate | |
| JP2006519812A (ja) | フェニルスルホン誘導体およびｃｎｓ障害の治療におけるその使用 | |
| WO1992005165A1 (en) | Diphenylpiperazine derivative and drug for circulatory organ containing the same | |
| CN1602311A (zh) | 2－氨基－4－吡啶基甲基－二氢噻唑衍生物作为诱导型no－合酶抑制剂的用途 | |
| JP2008540595A5 (https=) | ||
| CN1578768A (zh) | 邻氨基苯甲酰胺及其药学应用 | |
| US7309709B2 (en) | Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders | |
| US20080188659A1 (en) | Method for Preparing Halogenated Amines | |
| BE898219A (fr) | Nouveaux dérivés d'amine, leurs sels, procédé pour les préparer, et agent anti-ulcéreux les contenant. | |
| EP1534280A1 (en) | Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol | |
| ZA200702457B (en) | Arylpiperazine derivatives and use thereof as 5-HT1A receptor ligands | |
| JP2005520942A5 (https=) | ||
| JP2005516018A (ja) | Ｎ，ｎ’−ジ置換されたピペラジン化合物及びこれを鎮痛剤として使用する方法 |